1st Quarter - Report

W STRATEGIES, LLC for GLAXOSMITHKLINE

Period 1st Quarter 2022 Filed Apr 19, 2022 Signed by Darren Willcox

Official filing
Firm
W STRATEGIES, LLC
Client
GLAXOSMITHKLINE
Income
$40,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R.5376: Build Back Better Act, including H.R.3: Elijah E. Cummings Lower Drug Costs Now Act, and H.R.19: Lower Costs, More Cures Act of 2021. H.R.1978: Protecting Seniors Through Immunizations Act of 2021.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 19 (117th), H.R. 1978 (117th), H.R. 3 (117th), H.R. 5376 (117th)

Health Issues HCR

Reauthorization of the Prescription Drug User Fee Act and related issues. Education around infectious disease therapies as it relates to COVID-19. H.R.2471 - Consolidated Appropriations Act, 2022. H.R.7007 - COVID Supplemental Appropriations Act, 2022.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7007 (117th), H.R. 2471 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.